Cargando…
MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression
The Hippo signaling axis is a tumor suppressor pathway that is activated by various extra‐pathway factors to regulate cell differentiation and organ development. Recent studies have reported that autophosphorylation of the core kinase cassette stimulates activation of the Hippo signaling cascade. He...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690468/ https://www.ncbi.nlm.nih.gov/pubmed/37905571 http://dx.doi.org/10.15252/embj.2023114558 |
_version_ | 1785152533312831488 |
---|---|
author | Sun, Yan Jin, Xin Meng, Junpeng Guo, Feng Chen, Taoyu Zhao, Xiaoyan Wu, Heshui Ren, Dianyun |
author_facet | Sun, Yan Jin, Xin Meng, Junpeng Guo, Feng Chen, Taoyu Zhao, Xiaoyan Wu, Heshui Ren, Dianyun |
author_sort | Sun, Yan |
collection | PubMed |
description | The Hippo signaling axis is a tumor suppressor pathway that is activated by various extra‐pathway factors to regulate cell differentiation and organ development. Recent studies have reported that autophosphorylation of the core kinase cassette stimulates activation of the Hippo signaling cascade. Here, we demonstrate that protein arginine methyltransferase 5 (PRMT5) contributes to inactivation of the Hippo signaling pathway in pancreatic cancer. We show that the Hippo pathway initiator serine/threonine kinase 3 (STK3, also known as MST2) of Hippo signaling pathway can be symmetrically di‐methylated by PRMT5 at arginine‐461 (R461) and arginine‐467 (R467) in its SARAH domain. Methylation suppresses MST2 autophosphorylation and kinase activity by blocking its homodimerization, thereby inactivating Hippo signaling pathway in pancreatic cancer. Moreover, we also show that the specific PRMT5 inhibitor GSK3326595 re‐activates the dysregulated Hippo signaling pathway and inhibits the growth of human pancreatic cancer xenografts in immunodeficient mice, thus suggesting potential clinical application of PRMT5 inhibitors in pancreatic cancer. |
format | Online Article Text |
id | pubmed-10690468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106904682023-12-02 MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression Sun, Yan Jin, Xin Meng, Junpeng Guo, Feng Chen, Taoyu Zhao, Xiaoyan Wu, Heshui Ren, Dianyun EMBO J Articles The Hippo signaling axis is a tumor suppressor pathway that is activated by various extra‐pathway factors to regulate cell differentiation and organ development. Recent studies have reported that autophosphorylation of the core kinase cassette stimulates activation of the Hippo signaling cascade. Here, we demonstrate that protein arginine methyltransferase 5 (PRMT5) contributes to inactivation of the Hippo signaling pathway in pancreatic cancer. We show that the Hippo pathway initiator serine/threonine kinase 3 (STK3, also known as MST2) of Hippo signaling pathway can be symmetrically di‐methylated by PRMT5 at arginine‐461 (R461) and arginine‐467 (R467) in its SARAH domain. Methylation suppresses MST2 autophosphorylation and kinase activity by blocking its homodimerization, thereby inactivating Hippo signaling pathway in pancreatic cancer. Moreover, we also show that the specific PRMT5 inhibitor GSK3326595 re‐activates the dysregulated Hippo signaling pathway and inhibits the growth of human pancreatic cancer xenografts in immunodeficient mice, thus suggesting potential clinical application of PRMT5 inhibitors in pancreatic cancer. John Wiley and Sons Inc. 2023-10-31 /pmc/articles/PMC10690468/ /pubmed/37905571 http://dx.doi.org/10.15252/embj.2023114558 Text en © 2023 The Authors. Published under the terms of the CC BY NC ND 4.0 license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Articles Sun, Yan Jin, Xin Meng, Junpeng Guo, Feng Chen, Taoyu Zhao, Xiaoyan Wu, Heshui Ren, Dianyun MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression |
title |
MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression |
title_full |
MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression |
title_fullStr |
MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression |
title_full_unstemmed |
MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression |
title_short |
MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression |
title_sort | mst2 methylation by prmt5 inhibits hippo signaling and promotes pancreatic cancer progression |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690468/ https://www.ncbi.nlm.nih.gov/pubmed/37905571 http://dx.doi.org/10.15252/embj.2023114558 |
work_keys_str_mv | AT sunyan mst2methylationbyprmt5inhibitshipposignalingandpromotespancreaticcancerprogression AT jinxin mst2methylationbyprmt5inhibitshipposignalingandpromotespancreaticcancerprogression AT mengjunpeng mst2methylationbyprmt5inhibitshipposignalingandpromotespancreaticcancerprogression AT guofeng mst2methylationbyprmt5inhibitshipposignalingandpromotespancreaticcancerprogression AT chentaoyu mst2methylationbyprmt5inhibitshipposignalingandpromotespancreaticcancerprogression AT zhaoxiaoyan mst2methylationbyprmt5inhibitshipposignalingandpromotespancreaticcancerprogression AT wuheshui mst2methylationbyprmt5inhibitshipposignalingandpromotespancreaticcancerprogression AT rendianyun mst2methylationbyprmt5inhibitshipposignalingandpromotespancreaticcancerprogression |